SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-005965
Filing Date
2017-02-03
Accepted
2017-02-03 17:23:41
Documents
4
Period of Report
2017-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v458392_8k.htm 8-K 41592
2 EXHIBIT 2.1 v458392_ex2-1.htm EX-2.1 37413
3 EXHIBIT 10.1 v458392_ex10-1.htm EX-10.1 51203
4 EXHIBIT 10.2 v458392_ex10-2.htm EX-10.2 45051
  Complete submission text file 0001144204-17-005965.txt   176521
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36439 | Film No.: 17573187
SIC: 3826 Laboratory Analytical Instruments